mRNA vaccine development for cholangiocarcinoma: a precise pipeline

Your Location：

Home >

Browse articles >

mRNA vaccine development for cholangiocarcinoma: a precise pipeline

PERSPECTIVE | Updated：2023-05-10

- mRNA vaccine development for cholangiocarcinoma: a precise pipeline
- Tian-Yu Tang , Xing Huang , Gang Zhang , Ming-Hao Lu , Ting-Bo Liang
- Military Medical Research Vol. 10, Issue 2, Pages: 262-267(2023)
- Affiliations：
  1.Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
  2.Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
  3.Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou 310003, China
  4.Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou 310009, China
  5.Cancer Center, Zhejiang University, Hangzhou 310058, China
- Author bio：
  * huangxing66@zju.edu.cn;
  liangtingbo@zju.edu.cn
- Funds：
- DOI： 10.1186/s40779-022-00399-8
  CLC：
- Accepted：
Scan QR Code
DOI：
DOI：

Full Text(HTML)
Figs( 0 ) Tabs( 2 )
References
Publication Info
Metrics

摘要

Abstract

关键词

Keywords

references

31

Views

23

Downloads

0

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Related Articles

Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine

Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance

MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Related Author

Ting-Bo Liang

Xiang Gao

Tian-Yu Tang

Gang Zhang

Xing Huang

Ji-Xin Zhong

Zi-Jun Ma

Jun Chen

Related Institution

The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province

Key Laboratory of Vascular Aging (HUST), Ministry of Education

Department of Rheumatology, Fujian Medical University Union Hospital

Division of Rheumatology and Immunology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sinopharm Dongfeng General Hospital (Hubei Clinical Research Center of Hypertension), Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine